UNAIDS is the international movement working to end the HIV/AIDS epidemic worldwide by 2030, which aligns with the U.N.’s Sustainable Development Goals. Its fight against HIV/AIDS in East and Southern Africa has seen encouraging results.
In 2016, UNAIDS created the 90-90-90 targets for 2020, aiming to have 90 percent of all people with HIV know they are HIV positive, 90 percent of those who know their status receive antiretroviral therapy (ART) consistently and 90 percent of those receiving treatment show viral suppression (having no symptoms of HIV/AIDS).
HIV/AIDS in East and Southern Africa a Main Target of UNAIDS
East and Southern Africa is the region of the world most impacted by HIV/AIDS. UNAIDS estimates that 19.4 million people in that region have HIV/AIDS. However, since the creation of the 90-90-90 targets and the subsequent implementation of more rigorous prevention and treatment programs, tremendous progress has been made towards curbing the transmission of and deaths from HIV/AIDS.
These statistics show how East and Southern Africa are faring in each of the 90-90-90 categories:
- Knowing Status
According to a UNAIDS Special Analysis from 2017, in 2016, 14.7 million of an estimated 19.4 million people with HIV/AIDS in East and Southern Africa knew their status. That is 76 percent, up from 72 percent the previous year.
- Receiving Antiretroviral Therapy
Seven million people with HIV/AIDS in East and Southern Africa are on ART. This means that 60 percent of all people with HIV (up from 53 percent in 2015)—or 79 percent of those who know their status—are receiving treatment.
- Showing Viral Suppression
Seven million people on ART in this region show suppressed viral loads. Thus, 50 percent of people with HIV in East and Southern Africa (up from 45 percent in 2015)—which is equivalent to 83 percent of those receiving ART—show viral suppression.
Both the infection rate and death rate from HIV/AIDS are improving. Infection rates peaked between 1995 and 1998, when UNAIDS estimates that 1.7 million people in East and Southern Africa were newly infected each year. The decline began in 1990 and has continued. In 2016, UNAIDS estimated that 790,000 people contracted HIV/AIDS, down from 850,000 a year before.
Deaths from HIV/AIDS in East and Southern Africa peaked about a decade later than infection rates did, with approximately one million people dying annually between 2004 and 2006. In 2010, 720,000 people died from HIV/AIDS. By 2016, that number had dropped by nearly 50 percent to 420,000 deaths. As UNAIDS notes, it is extraordinary to see a death rate cut nearly in half in just six years.
Much of this recent success must be attributed to the work of UNAIDS, which is working to make testing and treatment of HIV/AIDS available to everyone. Its programs specifically target young women, pregnant mothers-to-be and males who, because of the stigma around HIV/AIDS, are often the least likely to receive proper treatment.
Multi-Pronged Efforts Reach Most Vulnerable Populations
Efforts aimed at young females including getting comprehensive sex education into all primary and secondary schools in East and Southern Africa, encouraging girls to stay in school (and away from dangerous sex work), and providing easily accessible female and reproductive healthcare.
UNAIDS is also helping to equip maternity clinics with what they need to ensure that all pregnant women will be aware of their HIV status and are able to get the care they need to have a healthy pregnancy.
Along with working to end the stigma around HIV/AIDS and providing accessible places to receive testing and treatment, UNAIDS aims to distribute 30 male condoms to every man living in the region each year. It also offers voluntary male circumcision programs, which can help prevent female to male HIV transmission.
East and Southern Africa may be the region most affected by HIV/AIDS, but UNAIDS is doing tremendous work towards achieving its 90-90-90 goals by 2020 and its goal of ending the HIV/AIDS epidemic by 2030. Continuing to spread awareness about HIV/AIDS and making testing and treatment increasingly available will ensure that these successes continue.
– Abigail Dunn